CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 22 target
Drug / intervention
Arm Cycle Ergometry +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07508904
NCT07508904N/ARecruitingOn TrackUpdated 2mo ago

Effects of Upper and Lower Limb Exercises on Muscle Strength, Aerobic Capacity and Respiratory Functions in Children With Cystic Fibrosis

Riphah International University·interventional·Posted Apr 2, 2026·Updated Apr 2, 2026

In Brief

A clinical study evaluating Arm Cycle Ergometry and Leg Cycle Ergometry for Cystic Fibrosis (CF). Currently recruiting, targeting 22 participants across 1 site.

Detailed Summary

This research aims to evaluate the effects of upper and lower limb exercises on muscle strength and pulmonary function in children diagnosed with CF. While aerobic training is a known component of CF management, resistance training focused on specific limb groups has gained attention for its additional benefits. Upper limb exercises may aid respiratory muscle endurance and thoracic mobility, enhancing pulmonary mechanics. In contrast, lower limb exercises (such as cycling or squats) are associated with improved oxygen consumption (VO₂ peak), enhanced mobility, and greater lower body strength. This randomized clinical trial will be conducted using a non-probability convenience sampling technique. The study will take place at the pediatric cystic fibrosis centers of Gulab Devi Chest Hospital and The Children's Hospital, Lahore. The targeted population includes children aged 6 to 18 years who have been diagnosed with cystic fibrosis and referred to the physiotherapy department. The study duration will be ten months following the approval of the synopsis. Eligible participants will be children aged between 6 and 18 years, clinically diagnosed with cystic fibrosis, currently stable with no history of hospitalization or significant lung infection in the past month. They should be physically able to participate in exercise and capable of following instructions, with informed consent obtained from their parents or guardians. Children will be excluded if they suffer from other severe lung diseases, cardiovascular or orthopedic conditions that restrict exercise, recent surgery or hospitalization within the last month, or if they are unable to understand instructions. Those dependent on oxygen therapy or ventilator support at all times will also be excluded. The primary outcome measures will include lung function assessed by spirometry (FVC, FEV1), sputum production recorded through a sputum diary, and aerobic capacity measured by the Incremental Shuttle Walk Test (ISWT). Muscle strength will be evaluated for both upper and lower limbs, using a handheld dynamometer for the upper limbs and the Sit-to-Stand Test for the lower limb

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesPakistan
Collaborators--

Timeline

N/ARecruiting
2026
First PostedApr 2, 2026
Enrollment StartDec 1, 2025
Primary CompletionAug 1, 2026
Study CompletionSep 1, 2026
TodayJul 1, 2026
Enrollment to primary: 8 monthsPosted 3 months agoPrimary completion in 1 month

Interventions

Arm Cycle Ergometryother

Participants will undergo upper limb resistance training using an arm cycle ergometer

Leg Cycle Ergometryother

Participants will undergo lower limb resistance training using a leg cycle ergometer